Genenta Science S.p.A.
NASDAQ:GNTA
5.3 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.021 | 0 | 0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.021 | 0 | -0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0.001 | 0.001 | 3.885 | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 | 0 | 0 | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 |
General & Administrative Expenses
| 0.001 | 0.001 | 0.001 | 0.001 | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 2.31 | 0 | 2.829 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 0.001 | 0.001 | 2.831 | 0.001 | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 0.002 | 0.003 | 6.716 | 0.003 | 0.003 | 0.003 | 0.001 | 0.001 | 0.001 | 0.001 | 0.002 | 0.002 | 0.002 | 0.002 | 0.001 | 0.001 |
Operating Income
| -0.002 | -0.002 | -6.737 | -0.003 | -0.003 | -0.003 | -0.002 | -0.002 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0 | 0 | 0.041 | 0 | 0 | 0 | 0.001 | 0.001 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
Income Before Tax
| -0.002 | -0.002 | -6.696 | -0.003 | -0.003 | -0.003 | -0.001 | -0.001 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income
| -0.002 | -0.002 | -6.696 | -0.003 | -0.003 | -0.003 | -0.001 | -0.001 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.13 | -0.13 | -0.37 | -0.19 | -0.17 | -0.17 | -0.058 | -0.058 | -0.048 | -0.048 | -0.14 | -0.14 | -0.11 | -0.11 | -0.086 | -0.086 |
EPS Diluted
| -0.13 | -0.13 | -0.37 | -0.19 | -0.17 | -0.17 | -0.058 | -0.058 | -0.048 | -0.048 | -0.14 | -0.14 | -0.11 | -0.11 | -0.086 | -0.086 |
EBITDA
| -0.002 | -0.002 | -6.716 | -0.003 | -0.003 | -0.003 | -0.002 | -0.002 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |